Skip to main content
SpringerLink
Log in

Development of a Novel Controlled-Release System for Gastric Retention

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. We report on the development of a novel controlled-release gastric retention system, which consists of a matrix tablet, coated with a permeable membrane. When immersed in simulated gastric fluid, the tablet expands. The tablet remains expanded for eighteen to twenty hours, during which time the drug is released. The tablet then either disintegrates into fragments or loses its integrity.

Methods. Tablets containing a soluble drug (chlorpheniramine maleate, i.e., CPM) and a poorly soluble drug (riboflavin 5′ phosphate, i.e., R5′P) were compressed. They were coated with a permeable and elastic polymer (Eudragit®). Dissolution profiles of these tablets were studied. The changes in the pH, viscosity, and deformation characteristics as a function of time were measured.

Results. Carbopol® provided a firm structure to the swollen tablet. Polyvinyl pyrrolidone XL (PVP XL) contributed to the swelling of the tablet. Carbonates provided the initial alkaline micro-environment for Carbopol® to gel and conferred buoyancy to the tablet. Coating provided the support needed for the core to remain intact during drug release and, at the same time, it allowed drug release due to its permeable nature. During release, the gelling properties of Carbopol® lessened, resulting in a decrease in the firmness of the core. This was evident from the decrease in the viscosity of the core. The energy required at 50% strain also decreased as the drug release progressed.

Conclusions. When this tablet is ingested, the chances of its elimination through the pylorus should be greatly reduced due to tablet's expansion, and due to its disintegration or loss in integrity it should then be expelled out of the stomach at the end of the drug release.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. R. H. Johnson and E. L. Rowe. US Patent # 3574820, 1971.

  2. R. C. Mamajek and E. S. Moyer. US Patent # 4207890, 1980.

  3. J. Urquhart and F. Theeuwes. US Patent # 4434153, 1984.

  4. L. J. Caldwell, C. R. Gardner, and R. C. Cargill. U.S. Patent # 4735804, 1988.

  5. L. J. Caldwell, C. R. Gardner, R. C. Cargill, and T. Higuchi. U.S. Patent # 4758436, 1988.

  6. L. J. Caldwell, C. R. Gardner, and R. C. Cargill. U.S. Patent # 4767627, 1988.

  7. R. Cargill, L. J. Caldwell, K. Engle, J. A. Fix, P. A. Porter, and C. R. Gardner. Pharm. Res. 5(8):533–536 (1988).

    PubMed  Google Scholar 

  8. S. Watanabe, M. Kayano, Y. Ishino, and K. Miyao. U.S. Patent # 3976764, 1976.

  9. P. R. Sheth and J. L. Tossounian. U.S. Patent # 4126672, 1978.

  10. S. Bolton and S. Desai. U.S. Patent # 4814179, 1989.

  11. J. D. Cook, M. Carriage, S. G. Kahn, W. Scalch, and B. S. Skikne. Lancet 335:1136–1139 (1990).

    PubMed  Google Scholar 

  12. M. Oth, M. Franz, J. Timmermans, and A. Moes. Pharm. Res. 9(3):298–302 (1992).

    PubMed  Google Scholar 

  13. K. Park and J. R. Robinson. Int. J. Pharmaceut. 19:107–127 (1984).

    Google Scholar 

  14. M. A. Longer, H. S. Ch'ng, and J. R. Robinson. J. Pharm. Sci. 74(4):406–411 (1985).

    PubMed  Google Scholar 

  15. J. L. Nunez Recuro, M. P. Ballesteros Papantonakis, and J. L. Lastres Garcia. S. T. P. Pharma Sciences 1(5):313–317 (1991).

    Google Scholar 

  16. S. P. Li, C. M. Pendharkar, G. N. Mehta, M. G. Karth, and K. M. Feld. Drug Dev. Ind. Res. 19(19):2519–2537 (1993).

    Google Scholar 

  17. N. Mazer, E. Abisch, J-C. Gfeller, R. Laplanche, P. Bauerfeind, M. Cucala, M. Lukachich, and A. Blum. J. Pharm. Sci. 77(8):647–657 (1988).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Pharmaceutics, University of Rhode Island, Kingston, Rhode Island, 02881, USA

    Arati A. Deshpande & Christopher T. Rhodes

  2. Hoffman-La Roche, Nutley, New Jersey, 07110, USA

    Navnit H. Shah & Waseem Malick

Authors
  1. Arati A. Deshpande
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Navnit H. Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christopher T. Rhodes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Waseem Malick
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deshpande, A.A., Shah, N.H., Rhodes, C.T. et al. Development of a Novel Controlled-Release System for Gastric Retention. Pharm Res 14, 815–819 (1997). https://doi.org/10.1023/A:1012171010492

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012171010492

Search

Navigation